Jazz Pharmaceuticals Competitors and Similar CompaniesClear all

Jazz Pharmaceuticals's competitors and similar companies include UCB and AlzProtect.
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
AlzProtect
AlzProtect
AlzProtect is a biopharmaceutical company discovering and developing drug candidates for the treatment of neurodegenerative diseases.
Founding Date
Founding Date
2003
Founding Date
1928
Founding Date
2007
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Dublin, IE HQ
Mississauga, CA
Vancouver, CA
Lyon, FR
München, DE
Roscommon, IE
Villa Guardia, IT
see more
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Locations
Loos, FR HQ
Loos, FR
Employees
Employees
2,800
Employees
9,052
Employees
1011% increase
Valuation ($)
Valuation ($)
6.9 b
Valuation ($)
34.3 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$4.3b (FY, 2025)
Revenue (est.)
€7.4b (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
($356.1m) (FY, 2025)
Net income
€1.6b (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 384.1m
Total funding raised
N/A
Total funding raised
$ 19.8m
For sources of this data, please see the company profile

View Company Profiles

UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company
AlzProtect
HQ
Loos, FR
Employees
10↑ 11% increase

AlzProtect is a biopharmaceutical company discovering and developing drug candidates for the treatment of neurodegenerative diseases.

View company